In contrast to the fluctuating global M&A market, the life sciences and health tech industry saw a significant uptick in deal-making throughout 2023, showcasing remarkable resilience and growth.
2.5.2024
Strong momentum in life sciences and health tech industry: Castrén & Snellman sees a significant uptick in deal-making
Karlo Siirala, Hanna Paloheimo, Sakari Lukinmaa, Tero Tuomisto & Antti Kaakkola
Related services
Despite initial setbacks due to the pandemic, the sector has witnessed a resurgence in mergers and acquisitions, and investments from both private equity and venture capital firms.
Notably, landmark transactions like Novo Nordisk’s USD 16.5 billion acquisition of Catalent and Pfizer’s USD 43 billion merger with Seagen underscore the magnitude and momentum of deal activity within the industry.
Castrén & Snellman’s recent transactional work vividly reflects this heightened industry activity. In 2023 and 2024, our firm has been deeply immersed in facilitating mergers and acquisitions, securing funding and refinancing and supporting manufacturing projects for innovative companies, investors and entrepreneurs in the health tech and life sciences sphere.
Our recent cases showcase Castrén & Snellman’s expertise in navigating complex legal matters within the life sciences and health tech industry:
- Advising Mérieux Equity Partners’ leveraged buyout of Labquality, a Nordic player specialised in EQA, CRO activities and regulatory affairs, with a strong local presence in Central and Eastern Europe
- Advising BYG4Lab and Keensight Capital on BYG4Lab’s acquisition of Finbiosoft, an innovative software company founded in 2011 with a mission to help laboratories reach higher quality and better efficiency
- Advising Keensight Capital, a leading growth buyout investor, on the Finnish legal aspects of the combination of Biovian and 3P Biopharmaceuticals, two leading biologics contract development and manufacturing organisations (CDMOs) backed by Keensight Capital, to establish 3PBIOVIAN, a new pan-European leader in its field
- Advising DigiTx Partners, a venture capital firm specialised in the digital health space, on the USD 10 million series A funding round of CardioSignal, the developer of the first technology to detect major heart diseases without specialised medical hardware
- Advising Inventure, Tesi and Presidio Ventures on the EUR 13.7 million series A funding round of Algorithmiq, a growth company developing quantum computing algorithms and solutions for drug development and discovery
- Advising Biovian, a globally operating GMP (Good Manufacturing Practice) contract development and manufacturing organisation (CDMO) of biopharmaceuticals, on its EUR 50 million manufacturing facility project in Turku, Finland
- Advising Biovian on the debt refinancing initiative and new funding package with Eurazeo to support organic growth and GeneCity facility expansion
- Advising Voisin Consulting Life Sciences on the acquisition of MedEngine, a leading medical science agency in the Nordics.
With favourable economic conditions driving acquisitions, continued interest from private equity and venture capital firms, and the strategic importance of acquisitions for fostering growth, we anticipate continued vibrancy in the industry through the remainder of 2024. In addition, advancements in technology and innovation within the industry are expected to fuel further investment and transactional activity.
Latest insights
Article published 22.4.2024 – Tax & Structuring
New green transition investments in Finland to receive up to EUR 150 million tax credit per project
Article published 27.2.2024 – Private Equity & Venture Capital
Mergers and Acquisitions: ESG Due Diligence requires legal expertise
Article published 31.1.2024 – Environment, Energy & Green Transition
Investments in the green transition require courage and cooperation
Article published 19.4.2023 – Private Equity & Venture Capital
Certainty is now an asset in the investment market
Mikko Alakare, Janne Juusela, Samuli Tarkiainen & Jarno Tanhuanpää
Lia Heasman, Anna Kuusniemi-Laine & Jarno Tanhuanpää
Jarno Tanhuanpää
Jarno Tanhuanpää, Janne Lauha & Karlo Siirala
Latest references
CapMan Buyout – Divestment of Renoa Group
We advised CapMan Buyout in the exit of Renoa Group. Renoa Group management together with Korpi Capital and other investors have acquired the group. Renoa Group is a Finnish established expert in the building technology sector specializing in detached houses in Finland and Sweden. Renoa is a major provider of turnkey domestic water & heating, sewer system and electricity network renovations, with significant operations also in Sweden. The Group reported sales of €35 million and employed c. 300 personnel across its 10 offices in Finland and 6 in Sweden. Korpi Capital is a Finnish investment company with holdings in 29 companies.
Case published 14.1.2025
24 Pesula – Investment transaction
We advised 24 Pesula group in a transaction where Juuri Partners made an investment in Finland’s largest self-service laundry chain, 24 Pesula. Juuri Partners’ investment supports 24 Pesula’s strategy of strengthening its domestic market leadership, developing digital services, and expanding internationally. 24 Pesula, founded in 1999, has established a strong market position in the self-service laundry market with over 50 locations in Finland. The company has its own production facilities in Nokia, Finland. In the UK, 24 Pesula currently operates in four locations, and the company plans to expand into other international markets in the coming years. Juuri Partners is a Finnish private equity company, which invests in Finnish growth focused SMEs and offers financing to established and profitable SMEs in Finland.
Case published 20.12.2024
Voima Ventures – Investment in Aisti Corporation
We represented Voima Ventures in the Series A funding round of Aisti Corporation. Aisti’s EUR 29 million funding round will support the construction of its first commercial factory in Kitee, Finland, enabling the company to scale production. Other investors include Maki.vc and Valve Ventures Consortium among others. Voima Ventures is a venture capital fund investing in top scientific deep tech ventures in the Nordics and Baltics. Aisti Corporation is an acoustic tiles manufacturer with sustainability and functionality at heart. Aisti’s acoustic tiles are made from highly renewable wood fibres. With the factory in Kitee, the company plans to achieve a production capacity of 2.5 million square meters annually.
Case published 13.12.2024
Omya Group – Acquisition of Distrupol
We advised Omya as a local counsel in its acquisition of Distrupol, a thermoplastics distributor and subsidiary of GPD Companies, Inc. (GPD). The acquisition is subject to regulatory approvals. Omya is a leading global producer of industrial minerals – mainly fillers and pigments derived from calcium carbonate and dolomite – and a worldwide distributor of specialty chemicals. Omya has 9,000 people employed across more than 50 countries. Distrupol is a European leader in the sales, marketing, distribution and application development of an extensive range of thermoplastic polymers and elastomers.
Case published 9.12.2024